You must be logged in to view the content from the NCCN Drugs & Biologics Compendium�. Login or Register now!
Acute Myeloid Leukemia	NCCN Acute Myeloid Leukemia Panel Members	NCCN Guidelines� for Acute Myeloid Leukemia
Anal Carcinoma	NCCN Anal Carcinoma Panel Members	NCCN Guidelines� for Anal Carcinoma
Bladder Cancer Bladder Cancer Upper GU Tract Tumors Urothelial Carcinoma of the Prostate	NCCN Bladder Cancer Panel Members	NCCN Guidelines� for Bladder Cancer
Bone Cancer Ewing�s Sarcoma Osteosarcoma	NCCN Bone Cancer Panel Members	NCCN Guidelines� for Bone Cancer
Breast Cancer Breast Cancer, Noninvasive Breast Cancer, Invasive Paget’s Disease Breast Cancer During Pregnancy	NCCN Breast Cancer Panel Members	NCCN Guidelines� for Breast Cancer
Central Nervous System Cancers Metastatic Central Nervous System Lesions Primary Central Nervous System Tumors	NCCN Central Nervous System Cancers Panel Members	NCCN Guidelines� for Central Nervous System Cancers
Cervical Cancer	NCCN Cervical Cancer Panel Members	NCCN Guidelines� for Cervical Cancer
Chronic Myelogenous Leukemia	NCCN Chronic Myelogenous Leukemia Panel Members	NCCN Guidelines� for Chronic Myelogenous Leukemia
Colon Cancer	NCCN Colon Cancer Panel Members	NCCN Guidelines� for Colon Cancer
Esophageal Cancer	NCCN Esophageal Cancer Panel Members	NCCN Guidelines� for Esophageal Cancer
Gastric Cancer	NCCN Gastric Cancer Panel Members	NCCN Guidelines� for Gastric Cancer
Head and Neck Cancers Ethmoid Sinus Tumors Maxillary Sinus Tumors Cancer of the Lip Cancer of the Oral Cavity Cancer of the Oropharynx Cancer of the Hypopharynx Occult Primary Cancer of the Glottic Larynx Cancer of the Supraglottic Larynx Cancer of the Nasopharynx Unresectable and Recurrent Head and Neck Cancers	NCCN Head and Neck Cancers Panel Members	NCCN Guidelines� for Head and Neck Cancers
Hepatobiliary Cancers Hepatocellular Carcinoma Gallbladder Cancer Intrahepatic Cholangiocarcinoma Extrahepatic Cholangiocarcinoma	NCCN Hepatobiliary Cancers Panel Members	NCCN Guidelines� for Hepatobiliary Cancers
Hodgkin Lymphoma Classical Hodgkin Lymphoma Lymphocyte-predominant Hodgkin Lymphoma	NCCN Hodgkin Lymphoma Panel Members	NCCN Guidelines� for Hodgkin Lymphoma
Kidney Cancer	NCCN Kidney Cancer Panel Members	NCCN Guidelines� for Kidney Cancer
Malignant Pleural Mesothelioma	NCCN Malignant Pleural Mesothelioma Panel Members	NCCN Guidelines� for Malignant Pleural Mesothelioma
Melanoma	NCCN Melanoma Panel Members	NCCN Guidelines� for Melanoma
Multiple Myeloma Multiple Myeloma Systemic Light Chain Amyloidosis	NCCN Multiple Myeloma Panel Members	NCCN Guidelines� for Multiple Myeloma
Myelodysplastic Syndromes	NCCN Myelodysplastic Syndromes Panel Members	NCCN Guidelines� for Myelodysplastic Syndromes
Neuroendocrine Tumors Carcinoid Tumors Islet Cell Tumors Adrenal Gland Tumors Pheochromocytoma Poorly Differentiated (Anaplastic) Multiple Endocrine Neoplasia Type 1	NCCN Neuroendocrine Tumors Panel Members	NCCN Guidelines� for Neuroendocrine Tumors
Non-Hodgkin's Lymphomas Chronic Lymphocytic Leukemia/ Small Lymphocytic Lymphoma Follicular Lymphoma Marginal Zone Lymphoma Gastric MALT Lymphoma Nongastric MALT Lymphoma Splenic Marginal Zone Lymphoma Mantle Cell Lymphoma Diffuse Large B-Cell Lymphoma Burkitt's Lymphoma Lymphoblastic Lymphoma AIDS-Related B-Cell Lymphoma Peripheral T-Cell Lymphoma Mycosis Fungoides and Sezary Syndrome Primary Cutaneous B-Cell Lymphoma Adult T-Cell Leukemia/Lymphoma	NCCN Non-Hodgkin's Lymphomas Panel Members	NCCN Guidelines� for Non-Hodgkin's Lymphomas
Non-Melanoma Skin Cancers	NCCN Non-Melanoma Skin Cancers Panel Members
Basal and Squamous Cell Skin Cancers		NCCN Guidelines� for Basal and Squamous Cell Skin Cancers
Dermatofibrosarcoma Protuberance (DFSP)		NCCN Guidelines� for Dermatofibrosarcoma Protuberance (DFSP)
Merkel Cell Carcinoma		NCCN Guidelines� for Merkel Cell Carcinoma
Non-Small Cell Lung Cancer	NCCN Non-Small Cell Lung Cancer Panel Members	NCCN Guidelines� for Non-Small Cell Lung Cancer
Occult Primary	NCCN Occult Primary Panel Members	NCCN Guidelines� for Occult Primary
Ovarian Cancer Epithelial Ovarian Cancer/Fallopian Tube Cancer/ Primary Peritoneal Cancer Germ Cell Ovarian Stromal	NCCN Ovarian Cancer Panel Members	NCCN Guidelines� for Ovarian Cancer
Pancreatic Adenocarcinoma	NCCN Pancreatic Adenocarcinoma Panel Members	NCCN Guidelines� for Pancreatic Adenocarcinoma
Prostate Cancer	NCCN Prostate Cancer Panel Members	NCCN Guidelines� for Prostate Cancer
Rectal Cancer	NCCN Rectal Cancer Panel Members	NCCN Guidelines� for Rectal Cancer
Small Cell Lung Cancer	NCCN Small Cell Lung Cancer Panel Members	NCCN Guidelines� for Small Cell Lung Cancer
Soft Tissue Sarcoma Soft Tissue Sarcoma of the Extremity/Trunk Retroperitoneal/Intra-abdominal Angiosarcoma Gastrointestinal Stromal Tumors (GIST) Desmoid Tumors (Fibromatosis) Solitary Fibrous Tumor/Hemangiopericytoma Pigmented Villonodular Synovitis/Tenosynovial Giant Cell Tumor Alveolar Soft Part Sarcoma PEComa/Recurrent Angiomyolipoma/Lymphangioleiomyomatosis Chordoma	NCCN Soft Tissue Sarcoma Panel Members	NCCN Guidelines� for Soft Tissue Sarcoma
Testicular Cancer	NCCN Testicular Cancer Panel Members	NCCN Guidelines� for Testicular Cancer
Thymic Malignancies	NCCN Thymic Malignancies Panel Members	NCCN Guidelines� for Thymic Malignancies
Thyroid Carcinoma Papillary Carcinoma Follicular Carcinoma H�rthle Carcinoma Medullary Carcinoma	NCCN Thyroid Carcinoma Panel Members	NCCN Guidelines� for Thyroid Carcinoma
Uterine Neoplasms Endometrial Carcinoma Uterine Sarcoma	NCCN Uterine Neoplasms Panel Members	NCCN Guidelines� for Uterine Neoplasms
Waldenstr�m's Macroglobulinemia/ Lymphoplasmacytic Lymphoma	NCCN Waldenstr�m's Macroglobulinemia/ Lymphoplasmacytic Lymphoma Panel Members	NCCN Guidelines� for Waldenstr�m's Macroglobulinemia/ Lymphoplasmacytic Lymphoma

NCCN Compendium Chapters for Detection, Prevention, & Risk Reduction of Cancer

Breast Cancer Risk Reduction

NCCN Breast Cancer Risk Reduction Panel Members

NCCN Guidelines� for Breast Cancer Risk Reduction

NCCN Compendium Chapters for Supportive Care

Antiemesis	NCCN Antiemesis Panel Members	NCCN Guidelines� for Antiemesis
Growth Factors
Cancer- and Chemotherapy-Induced Anemia	NCCN Cancer- and Chemotherapy-Induced Anemia Panel Members	NCCN Guidelines� for Cancer- and Chemotherapy-Induced Anemia
Myeloid Growth Factors	NCCN Myeloid Growth Factors Panel Members	NCCN Guidelines� for Myeloid Growth Factors
Venous Thromboembolic Disease	NCCN Venous Thromboembolic Disease Panel Members	NCCN Guidelines� for Venous Thromboembolic Disease

Disclaimer

The NCCN Guidelines are a statement of consensus of the authors regarding their views of currently accepted approaches to cancer treatment. The recommendations regarding the uses and indications in the NCCN Compendium have been derived directly from the NCCN Guidelines. The NCCN Compendium represents neither an all-inclusive listing of every drug and biologic nor every appropriate use and indication for drugs and biologics. The NCCN Templates are peer reviewed statements of consensus of their authors derived from the NCCN Guidelines for the conditions the NCCN Templates address. The NCCN Templates are not exhaustive and do not represent the full spectrum of care or treatment options described in the NCCN Guidelines or the NCCN Compendium or include all appropriate approaches or combinations of drugs or biologics for the treatment of cancer. A NCCN Template does not constitute an order.

To order the latest CD-ROM of the Complete Library of NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines™), please click here